Journal-Banner_rev

Meta-Analysis of Randomized Controlled Trials of Transanal Surgery Versus ESD for Rectal Lesions

Colorectal

Douglas K. Rex, MD, MASGE reviewing Saeed A, et al. Endoscopy. 2026 Aug 27.

This meta-analysis of randomized controlled trials comparing transanal endoscopic surgery (TES) with endoscopic submucosal dissection (ESD) for rectal neoplasms identified 5 studies (3 fully published and 2 abstracts) that included 307 patients in the TES arm and 317 who underwent ESD.

En bloc and R0 resection rates were very similar, as were bleeding and perforation rates. Mean hospital stay also did not differ significantly overall, although 3 of the 4 trials that reported it found shorter stays after ESD. Procedure time was significantly shorter with TES (mean difference, approximately 22 minutes). Recurrence rates trended in favor of ESD (1.70% vs 4.23%) but did not reach significance.


Comment:

This meta-analysis indicates no apparent differences yet in major outcomes between TES and ESD for rectal lesions. The study did not pool costs, but trials that have reported costs have favored ESD. Overall, the decision to choose TES versus ESD can still be reasonably based on factors such as local expertise and tumor features, including location within the rectum and the extent of fibrosis present.
Note to readers: At the time we reviewed this paper, its publisher noted that it was not in final form and that subsequent changes might be made.
drrex 2021 cropped headshot

Douglas K. Rex, MD, MASGE

Bio and Disclosures

Citation(s):

Saeed A, Baidoo L, Akbar H, et al. Endoscopic submucosal dissection versus transanal endoscopic surgery in rectal neoplasms: meta-analysis of randomized controlled trials and trial sequential analysis. Endoscopy. 2026 Aug 27. doi.org: 10.1055/a-2936-0686. Epub ahead of print.